Home / Products / Knockout Cell Lines

Knockout Cell Lines

Knockout cell lines provide defined loss-of-function models for studying gene activity in a controlled cellular background. By removing or disrupting a specific gene, researchers can directly evaluate its contribution to signaling pathways, disease phenotypes, drug sensitivity, cell growth, immune response, metabolism, differentiation, and other biological processes. As a key group of genome-edited cell lines, knockout cell lines are widely used in target validation, mechanism-of-action studies, functional screening, biomarker research, and disease model development.

Ascent Research offers CRISPR knockout cell lines across a range of commonly used mammalian cell line backgrounds. Our CRISPR KO cell line products are mainly generated using CRISPR RNP-based editing, in which Cas9 protein and guide RNA are delivered directly into cells. This non-viral strategy supports efficient gene disruption while avoiding unnecessary vector-based integration. Edited regions are typically confirmed by Sanger sequencing to verify the presence of target-site mutations and support reliable downstream use.

This category includes both clonal knockout cell lines and polyclonal KO cell pools. Clonal knockout cell lines are suitable when researchers require a more uniform genetic background and stable performance across repeated experiments. Polyclonal knockout cells, also called KO cell pools, provide a more economical option for early-stage screening, assay setup, pathway exploration, or projects where a mixed edited population is acceptable. These cell pools can help reduce cost and shorten project timelines before moving into single-cell clone selection.

In addition to standard knockout cell line products, Ascent Research supports custom cell line development for gene-specific knockout projects. Researchers can select host cell backgrounds based on disease relevance, pathway activity, assay compatibility, or comparison with parental and isogenic cell lines. Whether you need a knockout cell line for focused gene function research or multiple KO cell lines for broader screening applications, our engineered cell lines provide practical in vitro models for investigating gene loss and its biological consequences.

Showing 12 of 41685 results

TNS1 Knockout U2OS Cell Line

The TNS1 Knockout U2OS Cell Line is a CRISPR/Cas9-edited loss-of-function model for tensin 1 in U2OS human osteosarcoma cells. TNS1 bridges integrins to the actin…
Cat. No. ARG44176

TNIP1 Knockout HaCat Cell Line

The TNIP1 Knockout HaCat Cell Line is a CRISPR/Cas9-edited loss-of-function model derived from HaCaT human keratinocytes, designed to disrupt the TNIP1 gene. In normal cells,…
Cat. No. ARG44175

Tnfsf11 Knockout MLO-Y4 Cell Line

The Tnfsf11 Knockout MLO-Y4 Cell Line is a CRISPR/Cas9-edited mouse osteocyte-like line with disrupted Tnfsf11, abolishing RANKL expression. It eliminates the key osteoclastogenic cytokine, enabling…
Cat. No. ARG44174

Tnfsf11 Knockout 4T1 Cell Line

The Tnfsf11 Knockout 4T1 Cell Line is a CRISPR/Cas9-edited mouse mammary carcinoma line lacking RANKL (TNFSF11). Derived from the metastatic 4T1 model of triple?negative breast…
Cat. No. ARG44173

TNFRSF21 Knockout ARPE-19 Cell Line

The TNFRSF21 Knockout ARPE-19 Cell Line is a CRISPR/Cas9-edited knockout model disrupting Death Receptor 6 (DR6) in human retinal pigment epithelial cells. DR6, activated by…
Cat. No. ARG44172

TNFRSF1B Knockout Jurkat E6.1 Cell Line

The TNFRSF1B Knockout Jurkat E6.1 Cell Line is a CRISPR/Cas9-edited knockout cell line that disrupts the gene encoding tumor necrosis factor receptor 2 (TNFR2) in…
Cat. No. ARG44171

TNFRSF1A Knockout Jurkat E6.1 Cell Line

The TNFRSF1A Knockout Jurkat E6.1 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from human Jurkat E6.1 T cells, lacking functional TNFR1 (encoded by…
Cat. No. ARG44170

TNFRSF10B Knockout MIA PaCa-2 Cell Line

The TNFRSF10B Knockout MIA PaCa-2 Cell Line is a CRISPR/Cas9-edited human pancreatic adenocarcinoma cell line with targeted disruption of the death receptor 5 (DR5) gene.…
Cat. No. ARG44169

TNFAIP3 Knockout THP-1 Cell Line

The TNFAIP3 Knockout THP-1 Cell Line is a CRISPR/Cas9-edited knockout of the TNFAIP3 gene in THP-1 monocytic cells. A20 is a ubiquitin-editing enzyme that terminates…
Cat. No. ARG44168

TNF Knockout Jurkat E6.1 Cell Line

The TNF Knockout Jurkat E6.1 Cell Line is a CRISPR/Cas9-edited knockout cell line in which the TNF gene has been disrupted in the Jurkat E6.1…
Cat. No. ARG44167

TMEM97 Knockout U266 Cell Line

The TMEM97 Knockout U266 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from the human U266 multiple myeloma B lymphocyte line. It targets TMEM97,…
Cat. No. ARG44166

TMEM63A Knockout HEK293T Cell Line

The TMEM63A Knockout HEK293T Cell Line is a CRISPR/Cas9-edited loss-of-function model in HEK293T cells. TMEM63A is a mechanosensitive cation channel that mediates Ca2+ and Na+…
Cat. No. ARG44165

Loading products...